K190332

Substantially Equivalent

Aperio AT2 DX System

Applicant: Leica Biosystems Imaging, Inc.
Product code: PSY
Advisory panel: Pathology
Date received: 2019-02-14
Decision date: 2019-05-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Vista, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.